Sanofi (LON:0O59)
London · Delayed Price · Currency is GBP · Price in EUR 80.03
+1.07 (1.36%)
At close: Aug 1, 2025
CTI BioPharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 9,126 | 5,560 | 5,400 | 8,371 | 6,223 | 12,294 | Upgrade |
Depreciation & Amortization | 3,014 | 3,110 | 3,247 | 3,053 | 3,001 | 3,186 | Upgrade |
Other Amortization | 158 | 106 | 120 | 97 | 119 | 112 | Upgrade |
Loss (Gain) From Sale of Assets | -335 | -298 | -103 | -470 | -357 | -1,012 | Upgrade |
Asset Writedown & Restructuring Costs | 951 | 370 | 1,062 | -42 | 231 | 373 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -6,880 | Upgrade |
Loss (Gain) on Equity Investments | -29 | 82 | 293 | -45 | -15 | -339 | Upgrade |
Stock-Based Compensation | 292 | 278 | 260 | 234 | 244 | 274 | Upgrade |
Other Operating Activities | -3,649 | -44 | -1,457 | -879 | -389 | -301 | Upgrade |
Change in Accounts Receivable | -894 | -28 | -472 | -500 | 185 | -134 | Upgrade |
Change in Inventory | -195 | -477 | -866 | -918 | -357 | -593 | Upgrade |
Change in Accounts Payable | 898 | 789 | 258 | 340 | 451 | 86 | Upgrade |
Change in Other Net Operating Assets | 1,333 | -899 | 1,493 | 284 | 1,130 | 316 | Upgrade |
Operating Cash Flow | 11,214 | 9,081 | 10,258 | 10,526 | 10,522 | 7,418 | Upgrade |
Operating Cash Flow Growth | 38.15% | -11.47% | -2.55% | 0.04% | 41.84% | -3.85% | Upgrade |
Capital Expenditures | -1,696 | -1,733 | -1,619 | -1,529 | -1,478 | -1,254 | Upgrade |
Sale of Property, Plant & Equipment | 1,379 | 1,461 | 807 | 1,340 | 676 | 918 | Upgrade |
Cash Acquisitions | -554 | -1,901 | -2,535 | -987 | -5,594 | -5,336 | Upgrade |
Sale (Purchase) of Intangibles | -1,115 | -1,462 | -1,287 | -574 | -565 | -829 | Upgrade |
Investment in Securities | -838 | -623 | -92 | -353 | -269 | 10,233 | Upgrade |
Other Investing Activities | 10,599 | -149 | -1,474 | 28 | -68 | -113 | Upgrade |
Investing Cash Flow | 7,733 | -4,407 | -6,200 | -2,075 | -7,298 | 3,619 | Upgrade |
Short-Term Debt Issued | - | 59 | 751 | 216 | - | 282 | Upgrade |
Long-Term Debt Issued | - | - | 48 | 1,549 | - | 2,019 | Upgrade |
Total Debt Issued | 498 | 59 | 799 | 1,765 | - | 2,301 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -414 | - | Upgrade |
Long-Term Debt Repaid | - | -953 | -3,936 | -2,998 | -2,390 | -4,186 | Upgrade |
Total Debt Repaid | -2,162 | -953 | -3,936 | -2,998 | -2,804 | -4,186 | Upgrade |
Net Debt Issued (Repaid) | -1,664 | -894 | -3,137 | -1,233 | -2,804 | -1,885 | Upgrade |
Issuance of Common Stock | 195 | 187 | 195 | 188 | 186 | 203 | Upgrade |
Repurchase of Common Stock | -4,003 | -302 | -593 | -497 | -382 | -822 | Upgrade |
Common Dividends Paid | -4,772 | -4,704 | -4,454 | -4,168 | -4,008 | -3,937 | Upgrade |
Other Financing Activities | -97 | -50 | -63 | -111 | -48 | -44 | Upgrade |
Financing Cash Flow | -10,341 | -5,763 | -8,052 | -5,821 | -7,056 | -6,485 | Upgrade |
Foreign Exchange Rate Adjustments | -42 | -13 | -32 | 8 | 15 | -64 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | -167 | - | - | - | - | Upgrade |
Net Cash Flow | 8,564 | -1,269 | -4,026 | 2,638 | -3,817 | 4,488 | Upgrade |
Free Cash Flow | 9,518 | 7,348 | 8,639 | 8,997 | 9,044 | 6,164 | Upgrade |
Free Cash Flow Growth | 48.77% | -14.94% | -3.98% | -0.52% | 46.72% | -3.57% | Upgrade |
Free Cash Flow Margin | 20.81% | 16.59% | 21.02% | 22.32% | 23.09% | 16.50% | Upgrade |
Free Cash Flow Per Share | 7.65 | 5.85 | 6.88 | 7.16 | 7.19 | 4.89 | Upgrade |
Cash Interest Paid | 473 | 587 | 559 | 380 | 334 | 315 | Upgrade |
Cash Income Tax Paid | 3,212 | 3,291 | 2,623 | 2,452 | 1,280 | 2,051 | Upgrade |
Levered Free Cash Flow | 8,783 | -4,944 | 7,173 | 8,514 | 7,336 | 6,284 | Upgrade |
Unlevered Free Cash Flow | 9,131 | -4,543 | 7,541 | 8,765 | 7,562 | 6,571 | Upgrade |
Change in Net Working Capital | -2,614 | 10,385 | -1,744 | -996 | -888 | -345 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.